Free Trial
→ Massive new energy source found in Utah (From Stansberry Research) (Ad) Buy AGX Stock  Free AGX Stock Alerts

Argan (AGX) Financials

Argan logo
$203.11 +6.14 (+3.12%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$206.81 +3.70 (+1.82%)
As of 05/23/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Argan

Annual Income Statements for Argan

This table shows Argan's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 1/31/2025 1/31/2024 1/31/2023 1/31/2022 1/31/2021 1/31/2020 1/31/2019 1/31/2018 1/31/2017 1/31/2016 1/31/2015
Net Income / (Loss) Attributable to Common Shareholders		 85 32 33 38 24 -43 52 72 70 36 30
Consolidated Net Income / (Loss)		 85 32 35 36 24 -41 52 72 77 50 43
Net Income / (Loss) Continuing Operations		 85 32 35 36 24 -41 52 72 77 50 43
Total Pre-Tax Income 		111 49 46 47 25 -48 47 113 115 76 64
Total Operating Income		 88 36 42 45 23 -56 40 107 112 74 64
Total Gross Profit		 141 81 86 100 62 -6.82 82 149 147 99 84
Total Revenue		 874 573 455 509 392 239 482 893 675 413 383
Operating Revenue		 874 573 455 509 392 239 482 893 675 413 383
Total Cost of Revenue		 733 492 369 410 330 246 400 743 528 314 300
Operating Cost of Revenue		 733 492 369 410 330 246 400 743 528 314 300
Total Operating Expenses		 53 44 45 55 39 49 42 42 34 25 19
Selling, General & Admin Expense		 53 44 45 47 39 44 41 42 32 25 19
Total Other Income / (Expense), net		 23 12 4.33 2.55 1.86 8.08 6.98 5.65 2.28 1.10 0.23
Other Income / (Expense), net		 23 12 4.33 2.55 1.86 8.08 6.98 5.65 2.28 1.10 0.23
Income Tax Expense		 26 17 11 11 1.07 -7.05 -4.65 40 37 25 21
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 0.00 1.61 -2.54 -0.04 1.98 -0.17 0.34 7.10 14 13
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 0.62 -0.20 0.00 0.00 - - - - - - -
Basic Earnings per Share		 $6.35 $2.42 $2.35 $2.43 $1.52 ($2.73) $3.34 $4.64 $4.67 $2.46 $2.11
Weighted Average Basic Shares Outstanding		 13.45M 13.37M 14.08M 15.72M 15.67M 15.62M 15.57M 15.52M 15.07M 14.76M 14.43M
Diluted Earnings per Share		 $6.15 $2.39 $2.33 $2.40 $1.51 ($2.73) $3.32 $4.56 $4.50 $2.42 $2.05
Weighted Average Diluted Shares Outstanding		 13.91M 13.55M 14.18M 15.91M 15.83M 15.62M 15.69M 15.78M 15.63M 15.02M 14.82M
Weighted Average Basic & Diluted Shares Outstanding		 13.63M 13.24M 13.40M 14.82M 15.72M 15.64M 15.60M 15.50M 15.10M 14.80M 14.40M
Cash Dividends to Common per Share		 $1.35 $1.10 $1.00 $1.00 $3.00 $1.00 $1.00 $1.00 $1.00 $0.70 $0.70

Quarterly Income Statements for Argan

This table shows Argan's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
Period end date 1/31/2025 10/31/2024 7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023 10/31/2022 7/31/2022
Net Income / (Loss) Attributable to Common Shareholders		 33 26 19 6.12 14 4.16 12 2.51 15 7.11 3.54
Consolidated Net Income / (Loss)		 31 28 18 7.88 12 5.46 13 2.11 15 7.76 4.22
Net Income / (Loss) Continuing Operations		 31 28 18 7.88 12 5.46 13 2.11 15 7.76 4.22
Total Pre-Tax Income 		39 37 24 11 17 12 17 3.00 12 10 14
Total Operating Income		 33 30 19 6.52 12 7.86 13 3.63 9.56 9.54 13
Total Gross Profit		 48 44 31 18 24 19 24 14 20 22 24
Total Revenue		 232 257 227 158 165 164 141 104 119 118 118
Operating Revenue		 232 257 227 158 165 164 141 104 119 118 118
Total Cost of Revenue		 185 213 196 140 141 145 118 89 99 96 94
Operating Cost of Revenue		 185 213 196 140 141 145 118 89 99 96 94
Total Operating Expenses		 15 14 12 11 12 11 11 11 10 13 11
Selling, General & Admin Expense		 15 14 12 11 12 11 11 11 10 13 11
Total Other Income / (Expense), net		 5.97 6.65 5.60 4.79 5.25 3.73 4.12 -0.63 2.46 0.77 0.51
Other Income / (Expense), net		 5.97 6.65 5.60 4.79 5.25 3.73 4.12 -0.63 2.46 0.77 0.51
Income Tax Expense		 7.26 8.97 6.08 3.43 4.96 6.13 4.59 0.90 -3.21 2.55 9.69
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 -1.48 1.62 -1.27 1.76 -1.97 1.31 0.87 -0.40 - 0.65 0.69
Basic Earnings per Share		 $2.33 $2.07 $1.36 $0.59 $0.90 $0.41 $0.95 $0.16 $0.99 $0.56 $0.30
Weighted Average Basic Shares Outstanding		 13.45M 13.53M 13.40M 13.26M 13.37M 13.33M 13.40M 13.41M 14.08M 13.78M 14.13M
Diluted Earnings per Share		 $2.26 $2.00 $1.31 $0.58 $0.89 $0.40 $0.94 $0.16 $0.97 $0.56 $0.30
Weighted Average Diluted Shares Outstanding		 13.91M 14.03M 13.88M 13.57M 13.55M 13.56M 13.54M 13.55M 14.18M 13.81M 14.25M
Weighted Average Basic & Diluted Shares Outstanding		 13.63M 13.58M 13.50M 13.35M 13.24M 13.33M 13.32M 13.41M 13.40M 13.58M 13.88M
Cash Dividends to Common per Share		 $0.38 $0.38 $0.30 $0.30 $0.30 $0.30 $0.25 $0.25 $0.25 $0.25 $0.25

Annual Cash Flow Statements for Argan

This table details how cash moves in and out of Argan's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 1/31/2025 1/31/2024 1/31/2023 1/31/2022 1/31/2021 1/31/2020 1/31/2019 1/31/2018 1/31/2017 1/31/2016 1/31/2015
Net Change in Cash & Equivalents		 -52 23 -177 -16 199 3.05 43 -48 6.37 -173 61
Net Cash From Operating Activities		 168 117 -30 28 176 54 -112 -73 259 -33 93
Net Cash From Continuing Operating Activities		 168 117 -30 28 176 54 -112 -73 259 -33 93
Net Income / (Loss) Continuing Operations		 85 32 35 36 24 -41 52 72 77 50 43
Consolidated Net Income / (Loss)		 85 32 35 36 24 -41 52 72 77 50 43
Depreciation Expense		 1.91 2.01 2.98 3.37 3.72 3.51 3.42 2.78 2.04 0.78 0.55
Amortization Expense		 3.76 1.91 2.55 0.87 0.90 1.14 1.01 1.03 1.16 0.53 0.24
Non-Cash Adjustments To Reconcile Net Income		 25 -18 -16 39 12 34 -42 -131 118 2.23 2.02
Changes in Operating Assets and Liabilities, net		 51 99 -54 -51 136 56 -127 -18 60 -87 47
Net Cash From Investing Activities		 -194 -68 -63 -7.04 67 -36 171 39 -244 -131 -3.55
Net Cash From Continuing Investing Activities		 -194 -68 -63 -7.04 67 -36 171 39 -244 -131 -3.55
Purchase of Property, Plant & Equipment		 -6.58 -2.76 -3.37 -1.42 -1.70 -7.06 -8.60 -4.83 -2.81 -3.12 -2.94
Acquisitions		 -16 -5.11 0.00 -5.62 -1.33 0.00 - - - -17 -
Purchase of Investments		 -315 -219 -250 -90 -100 -195 -191 -543 -595 -252 -
Sale and/or Maturity of Investments		 149 160 190 90 170 166 370 588 354 138 -
Other Investing Activities, net		 -5.02 0.00 0.00 - - - 0.23 -1.50 - 3.96 -0.61
Net Cash From Financing Activities		 -26 -26 -83 -35 -45 -14 -16 -14 -8.86 -8.65 -28
Net Cash From Continuing Financing Activities		 -26 -26 -83 -35 -45 -14 -16 -14 -8.86 -8.65 -28
Repurchase of Common Equity		 -1.52 -12 -68 -20 0.00 0.00 - - - - -
Payment of Dividends		 -18 -15 -15 -16 -47 -16 -16 -17 -25 -10 -35
Other Financing Activities, net		 -6.27 1.10 0.07 1.43 1.64 1.63 0.10 3.16 16 1.73 6.87
Effect of Exchange Rate Changes		 0.32 -0.12 -0.54 -2.97 1.73 -0.47 - - - -0.57 -
Cash Income Taxes Paid		 31 14 6.67 14 - - - 44 37 26 19

Quarterly Cash Flow Statements for Argan

This table details how cash moves in and out of Argan's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
Period end date 1/31/2025 10/31/2024 7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023 10/31/2022 7/31/2022
Net Change in Cash & Equivalents		 -30 -57 25 11 11 -19 8.85 22 38 -7.28 -49
Net Cash From Operating Activities		 45 32 73 18 25 58 36 -1.25 43 -16 -17
Net Cash From Continuing Operating Activities		 45 32 73 18 25 58 36 -1.25 43 -16 -17
Net Income / (Loss) Continuing Operations		 31 28 18 7.88 12 5.46 13 2.11 15 7.76 4.22
Consolidated Net Income / (Loss)		 31 28 18 7.88 12 5.46 13 2.11 15 7.76 4.22
Depreciation Expense		 0.53 0.43 0.46 0.48 0.49 0.49 0.49 0.55 0.69 0.74 0.75
Amortization Expense		 3.46 0.10 0.10 0.10 1.61 0.10 0.10 0.10 1.94 0.21 0.23
Non-Cash Adjustments To Reconcile Net Income		 15 3.65 11 -4.38 -23 -2.87 -14 21 -13 -1.28 -0.61
Changes in Operating Assets and Liabilities, net		 -5.59 -0.41 44 14 33 55 37 -25 38 -24 -22
Net Cash From Investing Activities		 -67 -82 -43 -1.73 -5.72 -70 -20 29 -0.79 23 -0.40
Net Cash From Continuing Investing Activities		 -67 -82 -43 -1.73 -5.72 -70 -20 29 -0.79 23 -0.40
Purchase of Property, Plant & Equipment		 -1.37 -2.55 -2.35 -0.32 -0.61 -1.11 -0.39 -0.65 -0.79 -1.94 -0.40
Acquisitions		 -13 - - -3.31 -5.11 - - 0.00 - - -
Purchase of Investments		 -70 -102 -55 -87 - -69 -30 -120 - -75 -
Sale and/or Maturity of Investments		 23 23 15 89 - - 10 150 - 100 -
Net Cash From Financing Activities		 -8.45 -6.93 -5.56 -5.12 -8.00 -5.56 -6.00 -6.49 -9.03 -13 -30
Net Cash From Continuing Financing Activities		 -8.45 -6.93 -5.56 -5.12 -8.00 -5.56 -6.00 -6.49 -9.03 -13 -30
Repurchase of Common Equity		 -0.88 -0.46 - -0.19 -4.00 -1.73 -3.06 -3.68 -4.98 -10 -26
Payment of Dividends		 -5.01 -5.20 -4.04 -4.03 -4.00 -3.99 -3.34 -3.36 -4.05 -3.40 -3.48
Other Financing Activities, net		 -2.56 -1.28 -1.52 -0.91 -0.01 0.16 0.40 0.54 - - -
Effect of Exchange Rate Changes		 0.51 0.10 -0.15 -0.13 0.59 -1.04 -0.66 0.99 4.77 - -
Cash Income Taxes Paid		 16 6.00 5.83 3.31 7.28 3.75 2.76 0.51 0.36 - -

Annual Balance Sheets for Argan

This table presents Argan's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 1/31/2025 1/31/2024 1/31/2023 1/31/2022 1/31/2021 1/31/2020 1/31/2019 1/31/2018 1/31/2017 1/31/2016 1/31/2015
Total Assets		 836 598 489 554 603 488 477 543 644 410 391
Total Current Assets		 781 547 439 507 546 422 416 485 588 351 364
Cash & Equivalents		 145 197 174 350 367 167 164 122 167 161 334
Short-Term Investments		 380 215 152 90 90 160 132 312 356 114 -
Accounts Receivable		 176 47 50 27 29 37 36 26 55 64 27
Other Current Assets		 80 87 63 40 61 57 84 25 3.19 4.08 0.46
Plant, Property, & Equipment, net		 14 11 10 10 20 23 20 15 13 12 6.52
Total Noncurrent Assets		 40 40 40 32 36 43 41 42 43 47 20
Goodwill		 28 28 28 28 28 28 33 34 35 37 18
Intangible Assets		 1.83 2.22 2.61 3.32 4.10 5.00 6.14 7.15 8.18 9.34 1.85
Noncurrent Deferred & Refundable Income Taxes		 0.55 2.26 3.69 0.46 0.25 7.89 1.26 0.44 0.24 - -
Other Noncurrent Operating Assets		 10 7.52 6.02 - 3.76 2.41 0.29 0.43 0.09 0.12 -
Total Liabilities & Shareholders' Equity		 836 598 489 554 603 488 477 543 644 410 391
Total Liabilities		 484 307 209 228 280 147 82 185 352 188 216
Total Current Liabilities		 480 302 203 223 276 144 81 183 351 188 215
Accounts Payable		 97 39 56 42 53 35 40 100 102 46 38
Accrued Expenses		 83 82 50 53 51 36 33 35 40 35 16
Other Current Liabilities		 299 181 96 128 172 73 8.35 48 - - -
Total Noncurrent Liabilities		 4.51 5.03 6.09 4.96 4.14 2.48 0.96 1.28 1.20 0.22 0.81
Other Noncurrent Operating Liabilities		 4.51 5.03 6.09 - 4.14 2.48 0.96 - - - -
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 352 291 281 326 322 341 394 358 293 222 175
Total Preferred & Common Equity		 352 291 281 326 321 339 395 358 292 219 185
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 352 291 281 326 321 339 395 358 292 219 185
Common Stock		 171 167 165 161 156 151 147 146 138 120 112
Retained Earnings		 293 226 208 189 166 189 248 211 155 100 74
Treasury Stock		 -106 -98 -89 -20 -0.03 - - - - - -
Accumulated Other Comprehensive Income / (Loss)		 -6.54 -3.60 -2.88 -2.45 -1.08 -1.12 -0.35 1.42 -0.76 -0.57 -

Quarterly Balance Sheets for Argan

This table presents Argan's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 10/31/2024 7/31/2024 4/30/2024 10/31/2023 7/31/2023 4/30/2023 10/31/2022 7/31/2022 4/30/2022 10/31/2021
Total Assets		 769 727 624 564 506 476 411 423 493 613
Total Current Assets		 717 675 574 514 455 425 365 378 448 560
Cash & Equivalents		 175 233 208 186 205 196 136 143 192 392
Short-Term Investments		 331 252 209 212 142 121 151 176 175 90
Accounts Receivable		 132 95 60 50 45 61 38 25 36 36
Other Current Assets		 79 95 98 67 64 47 40 34 44 42
Plant, Property, & Equipment, net		 14 12 11 11 10 11 11 9.51 9.94 18
Total Noncurrent Assets		 38 40 39 39 40 40 35 35 35 35
Goodwill		 28 28 28 28 28 28 28 28 28 28
Intangible Assets		 1.92 2.02 2.12 2.32 2.41 2.51 2.73 2.94 3.18 3.42
Noncurrent Deferred & Refundable Income Taxes		 1.25 1.64 2.31 3.13 3.91 3.61 4.67 4.40 4.08 0.00
Other Noncurrent Operating Assets		 6.37 7.83 6.80 5.32 5.76 5.88 - - - 3.69
Total Liabilities & Shareholders' Equity		 769 727 624 564 506 476 411 423 493 613
Total Liabilities		 440 419 331 279 221 198 139 146 191 263
Total Current Liabilities		 436 415 328 274 216 192 135 142 186 259
Accounts Payable		 87 100 66 35 32 36 45 38 40 40
Accrued Expenses		 78 62 61 83 68 45 40 40 39 43
Other Current Liabilities		 271 254 200 156 116 111 49 64 107 176
Total Noncurrent Liabilities		 4.00 3.38 3.66 4.93 5.07 5.35 4.62 4.02 4.52 4.31
Other Noncurrent Operating Liabilities		 4.00 3.38 3.66 4.93 5.07 5.35 - 4.02 4.52 4.18
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 329 308 293 285 285 278 272 277 302 350
Total Preferred & Common Equity		 329 308 293 285 285 278 273 278 303 348
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 329 308 293 285 285 278 273 278 303 348
Common Stock		 171 168 167 166 165 164 164 163 162 160
Retained Earnings		 266 244 229 217 216 207 198 193 192 190
Treasury Stock		 -103 -100 -98 -94 -92 -90 -84 -74 -47 -
Accumulated Other Comprehensive Income / (Loss)		 -5.70 -4.08 -5.36 -4.65 -3.34 -2.47 -5.05 -4.40 -3.72 -1.81

Annual Metrics And Ratios for Argan

This table displays calculated financial ratios and metrics derived from Argan's official financial filings.

Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 1/31/2025 1/31/2024 1/31/2023 1/31/2022 1/31/2021 1/31/2020 1/31/2019 1/31/2018 1/31/2017 1/31/2016 1/31/2015
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 52.47% 26.00% -10.67% 29.87% 64.11% -50.43% -46.00% 32.26% 63.34% 7.87% 68.43%
EBITDA Growth		 121.12% 2.55% 0.46% 73.87% 168.43% -183.47% -55.64% -1.11% 53.27% 17.89% -7.08%
EBIT Growth		 127.26% 6.38% -2.26% 89.12% 152.10% -201.16% -58.08% -1.67% 51.69% 17.31% -7.17%
NOPAT Growth		 181.13% -23.31% -6.91% 53.27% 156.37% -188.43% -35.68% -9.45% 53.39% 14.26% 5.05%
Net Income Growth		 164.10% -6.76% -2.81% 49.96% 158.49% -178.49% -28.30% -6.56% 54.22% 15.53% 0.26%
EPS Growth		 157.32% 2.58% -2.92% 58.94% 155.31% -182.23% -27.19% 1.33% 85.95% 18.05% -26.26%
Operating Cash Flow Growth		 43.41% 488.74% -205.79% -83.86% 228.60% 147.69% -54.30% -128.10% 884.22% -135.39% -5.16%
Free Cash Flow Firm Growth		 18.39% 366.03% -382.93% -92.08% 271.87% 135.19% -50.93% -133.90% 551.14% -164.06% -12.11%
Invested Capital Growth		 -42.66% -172.58% 60.90% 15.15% -1,120.03% -86.54% 228.93% 67.07% -333.52% 66.52% -38.72%
Revenue Q/Q Growth		 8.42% 8.68% -1.47% 1.66% 14.36% -7.60% -14.52% -4.00% 15.46% 3.52% 12.59%
EBITDA Q/Q Growth		 27.30% 13.40% 36.76% -19.41% 260.51% -19.17% -18.74% -15.33% 31.87% -11.54% -3.00%
EBIT Q/Q Growth		 24.18% 11.26% 36.18% -20.60% 604.16% -16.89% -20.30% -15.83% 32.40% -12.12% -3.02%
NOPAT Q/Q Growth		 36.52% -13.10% 79.37% -23.70% 808.53% -11.25% -18.82% -16.93% 38.55% -18.08% -0.27%
Net Income Q/Q Growth		 29.27% -9.05% 81.30% -21.66% 238.13% -13.77% -15.26% -15.95% 17.66% -1.41% -0.36%
EPS Q/Q Growth		 28.66% -3.24% 55.33% -16.08% 228.26% -12.81% -14.87% -14.93% 21.29% 2.54% -9.69%
Operating Cash Flow Q/Q Growth		 13.57% -13.56% 65.16% -62.19% -2.34% 1,894.23% 24.70% -242.75% 30.39% 16.20% -40.44%
Free Cash Flow Firm Q/Q Growth		 4.41% -22.39% 63.48% -78.85% -1.34% 728.98% 21.86% -313.51% 45.13% -26.01% -44.12%
Invested Capital Q/Q Growth		 2.42% -7.80% -333.89% 13.51% -19.32% -76.83% 15.49% 43.99% -29.45% 8.90% 2.77%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 16.13% 14.10% 18.98% 19.58% 15.83% -2.85% 17.10% 16.73% 21.73% 24.07% 21.82%
EBITDA Margin		 13.37% 9.22% 11.33% 10.07% 7.52% -18.04% 10.71% 13.04% 17.44% 18.59% 17.01%
Operating Margin		 10.09% 6.36% 9.16% 8.74% 5.87% -23.36% 8.35% 11.98% 16.63% 18.00% 16.74%
EBIT Margin		 12.72% 8.53% 10.11% 9.24% 6.34% -19.99% 9.79% 12.61% 16.97% 18.27% 16.80%
Profit (Net Income) Margin		 9.78% 5.64% 7.63% 7.01% 6.07% -17.03% 10.76% 8.10% 11.47% 12.15% 11.34%
Tax Burden Percent		 76.85% 66.13% 75.44% 75.87% 95.68% 85.23% 109.85% 64.24% 67.60% 66.49% 67.51%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 23.15% 33.87% 24.56% 24.13% 4.32% 0.00% -9.85% 35.76% 32.40% 33.51% 32.49%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% -70.42% 402.66% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% -69.90% 400.56% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 59.35% -388.88% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 26.59% 11.32% 11.44% 11.02% 7.18% -11.07% 13.79% 22.24% 30.10% 25.30% 26.12%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 82.13% -132.39% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 15.50% 9.00% 8.82% 8.14% 4.57% -9.91% 9.26% 18.97% 21.73% 18.85% 18.02%
Return on Assets (ROA)		 11.92% 5.95% 6.65% 6.18% 4.37% -8.44% 10.18% 12.19% 14.69% 12.54% 12.16%
Return on Common Equity (ROCE)		 26.59% 11.32% 11.46% 11.00% 7.14% -11.05% 13.79% 22.20% 29.85% 25.76% 26.83%
Return on Equity Simple (ROE_SIMPLE)		 24.29% 11.12% 12.35% 10.94% 7.43% -12.00% 13.15% 20.20% 26.55% 22.98% 23.43%
Net Operating Profit after Tax (NOPAT)		 68 24 31 34 22 -39 44 69 76 49 43
NOPAT Margin		 7.75% 4.21% 6.91% 6.63% 5.62% -16.36% 9.17% 7.70% 11.24% 11.97% 11.30%
Net Nonoperating Expense Percent (NNEP)		 3.77% 2.24% 0.85% 0.43% 0.45% -0.52% 2.10% 0.76% 0.39% 0.24% 0.05%
Return On Investment Capital (ROIC_SIMPLE)		 19.26% 8.29% 11.19% - - - - - - - -
Cost of Revenue to Revenue		 83.87% 85.90% 81.02% 80.42% 84.17% 102.85% 82.90% 83.27% 78.27% 75.93% 78.18%
SG&A Expenses to Revenue		 6.04% 7.74% 9.82% 9.29% 9.95% 18.46% 8.44% 4.68% 4.81% 6.06% 5.08%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 6.04% 7.74% 9.82% 10.84% 9.95% 20.51% 8.75% 4.74% 5.10% 6.06% 5.08%
Earnings before Interest and Taxes (EBIT)		 111 49 46 47 25 -48 47 113 115 76 64
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 117 53 52 51 30 -43 52 116 118 77 65
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.28 2.00 1.81 1.68 1.94 1.67 1.40 1.54 3.10 1.61 1.84
Price to Tangible Book Value (P/TBV)		 5.77 2.24 2.03 1.86 2.16 1.85 1.55 1.74 3.64 2.05 2.07
Price to Revenue (P/Rev)		 2.12 1.02 1.12 1.08 1.59 2.37 1.14 0.62 1.34 0.85 0.89
Price to Earnings (P/E)		 21.73 18.01 15.37 14.34 26.12 0.00 10.61 7.66 12.87 9.68 11.21
Dividend Yield		 0.99% 2.52% 2.67% 2.87% 3.15% 2.76% 3.53% 2.82% 0.51% 2.95% 2.98%
Earnings Yield		 4.60% 5.55% 6.51% 6.98% 3.83% 0.00% 9.43% 13.05% 7.77% 10.33% 8.92%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 18.21 2.61 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 1.52 0.30 0.40 0.21 0.43 1.00 0.53 0.13 0.57 0.19 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 11.40 3.22 3.55 2.09 5.69 0.00 4.94 1.01 3.25 1.04 0.00
Enterprise Value to EBIT (EV/EBIT)		 11.98 3.48 3.98 2.27 6.75 0.00 5.41 1.05 3.34 1.06 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 19.65 7.06 5.83 3.17 7.62 0.00 5.78 1.71 5.05 1.62 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 7.95 1.46 0.00 3.77 0.95 4.48 0.00 0.00 1.48 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 11.14 1.69 0.00 7.97 0.99 5.26 0.00 0.00 1.51 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.46 -1.29 -1.26 -1.38 -1.18 -0.85 -0.97 -1.47 -1.55 -1.53 -1.82
Leverage Ratio		 2.23 1.90 1.72 1.78 1.64 1.31 1.35 1.82 2.05 2.02 2.15
Compound Leverage Factor		 2.23 1.90 1.72 1.78 1.64 1.31 1.35 1.82 2.05 2.02 2.15
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% -0.24% 0.54% 0.52% -0.05% 0.01% 0.32% 1.51% -6.01%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.24% 99.46% 99.48% 100.05% 99.99% 99.68% 98.50% 106.01%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 4.71 3.39 3.88 3.74 3.04 3.71 6.93 5.34 3.95 3.56 3.19
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% -0.13% 0.15% 0.53% 0.22% -0.02% 0.15% 0.83% -1.81% -2.72%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.63 1.81 2.17 2.27 1.98 2.93 5.12 2.65 1.68 1.87 1.69
Quick Ratio		 1.46 1.52 1.85 2.10 1.76 2.53 4.09 2.51 1.65 1.81 1.68
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 120 101 -38 13 170 46 -130 -86 253 -56 88
Operating Cash Flow to CapEx		 2,545.71% 4,240.13% -891.49% 1,998.24% 10,372.01% 758.93% -1,306.22% -1,508.35% 9,215.37% -1,059.40% 3,178.78%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.22 1.05 0.87 0.88 0.72 0.50 0.95 1.50 1.28 1.03 1.07
Accounts Receivable Turnover		 7.84 11.77 11.80 18.29 11.90 6.52 15.44 22.01 11.34 9.03 15.02
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 68.61 53.46 43.57 33.05 18.28 11.30 27.49 62.85 53.11 43.90 71.60
Accounts Payable Turnover		 10.72 10.28 7.51 8.61 7.44 6.53 5.71 7.35 7.12 7.46 9.94
Days Sales Outstanding (DSO)		 46.58 31.02 30.93 19.95 30.67 56.02 23.64 16.58 32.18 40.41 24.30
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 34.05 35.52 48.61 42.38 49.05 55.91 63.97 49.63 51.24 48.90 36.73
Cash Conversion Cycle (CCC)		 12.54 -4.50 -17.68 -22.42 -18.39 0.11 -40.33 -33.05 -19.06 -8.49 -12.43
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -173 -121 -45 -114 -134 13 98 -76 -230 -53 -159
Invested Capital Turnover		 -5.93 -6.91 -5.74 -4.10 -6.47 4.31 43.92 -5.83 -4.76 -3.90 -2.80
Increase / (Decrease) in Invested Capital		 -52 -77 69 20 -147 -85 174 155 -177 106 -44
Enterprise Value (EV)		 1,332 170 183 107 168 240 255 118 383 80 -2.93
Market Capitalization		 1,857 583 509 548 623 566 552 552 905 352 341
Book Value per Share		 $25.92 $21.83 $20.69 $20.77 $20.44 $21.70 $25.34 $23.03 $19.05 $14.74 $12.76
Tangible Book Value per Share		 $23.72 $19.56 $18.43 $18.77 $18.40 $19.59 $22.84 $20.36 $16.24 $11.59 $11.37
Total Capital		 352 291 281 326 322 341 394 358 293 222 175
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -525 -412 -325 -440 -457 -328 -297 -434 -523 -275 -334
Capital Expenditures (CapEx)		 6.58 2.76 3.37 1.42 1.70 7.06 8.60 4.83 2.81 3.12 2.94
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -224 -167 -89 -156 -187 -50 39 -132 -286 -112 -185
Debt-free Net Working Capital (DFNWC)		 301 245 236 284 270 278 335 302 237 163 149
Net Working Capital (NWC)		 301 245 236 284 270 278 335 302 237 163 149
Net Nonoperating Expense (NNE)		 -18 -8.25 -3.27 -1.94 -1.78 1.62 -7.67 -3.63 -1.54 -0.73 -0.16
Net Nonoperating Obligations (NNO)		 -525 -412 -325 -440 -457 -328 -297 -434 -523 -275 -334
Total Depreciation and Amortization (D&A)		 5.66 3.92 5.54 4.24 4.62 4.65 4.43 3.81 3.21 1.31 0.79
Debt-free, Cash-free Net Working Capital to Revenue		 -25.59% -29.21% -19.62% -30.67% -47.58% -20.98% 7.99% -14.81% -42.33% -27.13% -48.23%
Debt-free Net Working Capital to Revenue		 34.48% 42.72% 51.91% 55.81% 68.88% 116.20% 69.49% 33.80% 35.14% 39.42% 38.87%
Net Working Capital to Revenue		 34.48% 42.72% 51.91% 55.81% 68.88% 116.20% 69.49% 33.80% 35.14% 39.42% 38.87%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $6.35 $2.42 $2.35 $2.43 $1.52 ($2.73) $3.34 $4.64 $4.67 $2.46 $2.11
Adjusted Weighted Average Basic Shares Outstanding		 13.45M 13.37M 14.08M 15.72M 15.67M 15.62M 15.57M 15.52M 15.07M 14.76M 14.43M
Adjusted Diluted Earnings per Share		 $6.15 $2.39 $2.33 $2.40 $1.51 ($2.73) $3.32 $4.56 $4.50 $2.42 $2.05
Adjusted Weighted Average Diluted Shares Outstanding		 13.91M 13.55M 14.18M 15.91M 15.83M 15.62M 15.69M 15.78M 15.63M 15.02M 14.82M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.63M 13.24M 13.40M 14.82M 15.72M 15.64M 15.58M 15.57M 15.47M 14.84M 14.63M
Normalized Net Operating Profit after Tax (NOPAT)		 68 24 31 40 22 -36 29 69 77 49 43
Normalized NOPAT Margin		 7.75% 4.21% 6.91% 7.81% 5.62% -14.92% 6.06% 7.74% 11.44% 11.97% 11.30%
Pre Tax Income Margin		 12.72% 8.53% 10.11% 9.24% 6.34% -19.99% 9.79% 12.61% 16.97% 18.27% 16.80%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 21.38% 45.38% 42.17% 43.87% 197.59% -38.37% 30.16% 23.19% 31.98% 20.67% 80.93%
Augmented Payout Ratio		 23.16% 83.90% 238.79% 100.92% 197.59% -38.37% 30.16% 23.19% 31.98% 20.67% 80.93%

Quarterly Metrics And Ratios for Argan

This table displays calculated financial ratios and metrics derived from Argan's official financial filings.

Metric Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
Period end date 1/31/2025 10/31/2024 7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023 10/31/2022 7/31/2022
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 41.28% 56.95% 60.61% 52.09% 38.54% 38.92% 19.68% 3.39% -5.41% -5.28% -11.20%
EBITDA Growth		 123.41% 207.96% 38.43% 225.84% 30.18% 8.16% 20.53% -66.00% 1,727.31% -32.60% -17.95%
EBIT Growth		 127.55% 218.97% 39.88% 276.60% 41.18% 12.46% 24.81% -69.22% 6,266.67% -34.18% -18.48%
NOPAT Growth		 219.61% 520.20% 43.74% 78.07% -31.51% -48.40% 139.35% -63.71% 1,569.52% -37.61% -68.86%
Net Income Growth		 161.02% 412.63% 42.54% 273.73% -21.14% -29.57% 202.39% -71.82% 4,817.96% -37.40% -67.20%
EPS Growth		 153.93% 400.00% 39.36% 262.50% -8.25% -28.57% 213.33% -68.00% 592.86% -28.21% -62.96%
Operating Cash Flow Growth		 81.44% -44.93% 105.29% 1,517.15% -42.71% 455.97% 310.03% 96.86% 423.15% -195.57% -157.13%
Free Cash Flow Firm Growth		 -8.06% -17.19% 343.09% 470.86% 248.72% 192.83% 127.80% 62.27% -170.57% -472.23% -230.29%
Invested Capital Growth		 -42.66% -57.59% -187.74% -216.00% -172.58% -997.20% -46.31% 40.45% 60.90% 92.21% 72.21%
Revenue Q/Q Growth		 -9.55% 13.21% 43.97% -4.18% 0.49% 15.85% 36.34% -12.72% 0.77% -0.20% 17.78%
EBITDA Q/Q Growth		 13.63% 50.99% 108.93% -32.30% 56.63% -32.13% 391.78% -71.57% 30.14% -24.36% 38.71%
EBIT Q/Q Growth		 4.47% 52.29% 114.63% -33.36% 46.44% -33.22% 477.86% -75.02% 16.65% -25.88% 42.53%
NOPAT Q/Q Growth		 15.45% 64.14% 208.19% -45.27% 124.03% -61.96% 281.81% -78.95% 68.77% 76.47% -42.11%
Net Income Q/Q Growth		 11.99% 53.92% 130.88% -34.42% 119.95% -57.20% 505.36% -86.16% 96.43% 83.75% -43.59%
EPS Q/Q Growth		 13.00% 52.67% 125.86% -34.83% 122.50% -57.45% 487.50% -83.51% 73.21% 86.67% -40.00%
Operating Cash Flow Q/Q Growth		 40.42% -56.76% 315.55% -28.09% -57.38% 61.20% 2,968.67% -102.91% 364.79% 4.89% 57.10%
Free Cash Flow Firm Q/Q Growth		 -10.85% -32.01% 45.61% 4.17% -19.71% 263.83% 221.87% 58.23% 49.89% -8.95% -65.41%
Invested Capital Q/Q Growth		 2.42% -0.55% -43.35% -1.43% -7.80% -83.58% -57.43% 12.51% -333.89% 75.52% 35.92%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 20.48% 17.25% 13.70% 11.38% 14.36% 11.75% 16.80% 13.72% 16.86% 18.84% 20.65%
EBITDA Margin		 18.33% 14.59% 10.94% 7.54% 11.59% 7.44% 12.70% 3.52% 12.34% 9.55% 12.61%
Operating Margin		 14.05% 11.80% 8.23% 4.13% 7.12% 4.80% 9.37% 3.50% 8.05% 8.09% 11.35%
EBIT Margin		 16.62% 14.39% 10.70% 7.17% 10.32% 7.08% 12.28% 2.90% 10.12% 8.75% 11.78%
Profit (Net Income) Margin		 13.49% 10.90% 8.02% 5.00% 7.30% 3.34% 9.03% 2.03% 12.83% 6.58% 3.57%
Tax Burden Percent		 81.20% 75.75% 74.95% 69.67% 70.79% 47.13% 73.55% 70.21% 126.73% 75.25% 30.36%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 18.80% 24.25% 25.05% 30.33% 29.21% 52.87% 26.45% 29.79% -26.73% 24.75% 69.64%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 26.59% 21.55% 14.69% 13.35% 11.32% 12.79% 13.48% 10.11% 11.44% 6.16% 7.70%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 20.25% 17.41% 12.38% 8.18% 10.88% 7.66% 12.74% 2.74% 8.83% 7.89% 10.26%
Return on Assets (ROA)		 16.45% 13.19% 9.28% 5.70% 7.70% 3.61% 9.37% 1.93% 11.19% 5.94% 3.12%
Return on Common Equity (ROCE)		 26.59% 21.55% 14.69% 13.35% 11.32% 12.80% 13.50% 10.13% 11.46% 6.15% 7.69%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 20.11% 14.14% 13.01% 0.00% 12.49% 13.29% 10.55% 0.00% 7.02% 8.56%
Net Operating Profit after Tax (NOPAT)		 27 23 14 4.54 8.30 3.70 9.74 2.55 12 7.18 4.07
NOPAT Margin		 11.41% 8.94% 6.17% 2.88% 5.04% 2.26% 6.89% 2.46% 10.20% 6.09% 3.44%
Net Nonoperating Expense Percent (NNEP)		 1.03% 1.11% 1.01% 0.91% 1.01% 0.52% 0.91% -0.13% 0.82% 0.15% 0.04%
Return On Investment Capital (ROIC_SIMPLE)		 7.54% - - - 2.85% - - - 4.31% - -
Cost of Revenue to Revenue		 79.52% 82.75% 86.30% 88.62% 85.64% 88.25% 83.20% 86.28% 83.14% 81.16% 79.35%
SG&A Expenses to Revenue		 6.43% 5.45% 5.47% 7.25% 7.24% 6.95% 7.43% 10.22% 8.81% 10.75% 9.30%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 6.43% 5.45% 5.47% 7.25% 7.24% 6.95% 7.43% 10.22% 8.81% 10.75% 9.30%
Earnings before Interest and Taxes (EBIT)		 39 37 24 11 17 12 17 3.00 12 10 14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 43 38 25 12 19 12 18 3.65 15 11 15
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.28 5.42 3.42 2.71 2.00 2.10 1.75 1.88 1.81 1.69 1.81
Price to Tangible Book Value (P/TBV)		 5.77 5.97 3.79 3.02 2.24 2.35 1.96 2.12 2.03 1.91 2.04
Price to Revenue (P/Rev)		 2.12 2.21 1.48 1.27 1.02 1.13 1.04 1.14 1.12 1.00 1.07
Price to Earnings (P/E)		 21.73 27.10 24.21 22.10 18.01 17.83 13.68 18.62 15.37 22.70 19.61
Dividend Yield		 0.99% 0.97% 1.52% 1.92% 2.52% 2.34% 2.69% 2.56% 2.67% 3.01% 2.83%
Earnings Yield		 4.60% 3.69% 4.13% 4.53% 5.55% 5.61% 7.31% 5.37% 6.51% 4.41% 5.10%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 1.52 1.58 0.80 0.60 0.30 0.38 0.32 0.45 0.40 0.38 0.39
Enterprise Value to EBITDA (EV/EBITDA)		 11.40 13.90 8.57 6.35 3.22 4.30 3.34 4.85 3.55 4.63 4.24
Enterprise Value to EBIT (EV/EBIT)		 11.98 14.25 8.87 6.61 3.48 4.56 3.57 5.27 3.98 5.16 4.67
Enterprise Value to NOPAT (EV/NOPAT)		 19.65 25.71 18.73 14.44 7.06 7.23 4.78 7.66 5.83 9.95 8.37
Enterprise Value to Operating Cash Flow (EV/OCF)		 7.95 8.65 3.28 2.79 1.46 1.48 2.49 24.56 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 11.14 11.14 3.91 3.43 1.69 1.54 2.97 395.34 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.46 -1.47 -1.40 -1.28 -1.29 -1.22 -1.18 -1.18 -1.26 -1.23 -1.31
Leverage Ratio		 2.23 2.17 2.08 1.93 1.90 1.75 1.65 1.67 1.72 1.65 1.74
Compound Leverage Factor		 2.23 2.17 2.08 1.93 1.90 1.75 1.65 1.67 1.72 1.65 1.74
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.29% -0.29%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.29% 100.29%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 4.42 4.56 3.50 3.49 3.21 3.34 3.59 3.77 3.65 4.54 4.59
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% -0.14% -0.14% -0.14% -0.13% 0.15% 0.15%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.63 1.64 1.63 1.75 1.81 1.88 2.11 2.21 2.17 2.71 2.66
Quick Ratio		 1.46 1.46 1.40 1.45 1.52 1.63 1.81 1.96 1.85 2.41 2.42
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 78 88 129 89 85 106 29 -24 -57 -114 -105
Operating Cash Flow to CapEx		 3,269.16% 1,247.70% 3,128.78% 5,492.55% 4,012.23% 5,189.75% 9,274.87% -193.49% 5,433.80% -833.95% -4,261.50%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.22 1.21 1.16 1.14 1.05 1.08 1.04 0.95 0.87 0.90 0.87
Accounts Receivable Turnover		 7.84 8.88 10.20 10.39 11.77 12.01 13.88 9.47 11.80 12.53 13.78
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 68.61 64.67 63.22 58.38 53.46 49.56 48.25 44.51 43.57 31.97 32.62
Accounts Payable Turnover		 10.72 11.33 9.47 10.56 10.28 11.29 11.52 9.90 7.51 8.76 9.11
Days Sales Outstanding (DSO)		 46.58 41.10 35.80 35.12 31.02 30.38 26.30 38.54 30.93 29.12 26.50
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 34.05 32.20 38.56 34.56 35.52 32.34 31.69 36.87 48.61 41.67 40.05
Cash Conversion Cycle (CCC)		 12.54 8.90 -2.76 0.56 -4.50 -1.96 -5.39 1.68 -17.68 -12.55 -13.55
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -173 -178 -177 -123 -121 -113 -61 -39 -45 -10 -42
Invested Capital Turnover		 -5.93 -5.56 -5.99 -7.74 -6.91 -8.58 -9.32 -8.78 -5.74 -6.50 -4.86
Increase / (Decrease) in Invested Capital		 -52 -65 -115 -84 -77 -102 -19 26 69 121 109
Enterprise Value (EV)		 1,332 1,276 569 378 170 201 153 207 183 174 183
Market Capitalization		 1,857 1,782 1,054 795 583 598 499 524 509 462 503
Book Value per Share		 $25.92 $24.35 $23.07 $22.14 $21.83 $21.39 $21.25 $20.75 $20.69 $19.63 $19.56
Tangible Book Value per Share		 $23.72 $22.13 $20.82 $19.86 $19.56 $19.11 $18.98 $18.47 $18.43 $17.41 $17.38
Total Capital		 352 329 308 293 291 285 285 278 281 272 277
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -525 -506 -485 -416 -412 -398 -346 -317 -325 -287 -319
Capital Expenditures (CapEx)		 1.37 2.55 2.35 0.32 0.61 1.11 0.39 0.65 0.79 1.94 0.40
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -224 -225 -225 -170 -167 -157 -107 -84 -89 -56 -83
Debt-free Net Working Capital (DFNWC)		 301 281 260 247 245 240 240 233 236 230 236
Net Working Capital (NWC)		 301 281 260 247 245 240 240 233 236 230 236
Net Nonoperating Expense (NNE)		 -4.84 -5.03 -4.20 -3.34 -3.72 -1.76 -3.03 0.44 -3.12 -0.58 -0.15
Net Nonoperating Obligations (NNO)		 -525 -506 -485 -416 -412 -398 -346 -317 -325 -282 -319
Total Depreciation and Amortization (D&A)		 3.99 0.53 0.56 0.58 2.10 0.59 0.59 0.65 2.63 0.95 0.98
Debt-free, Cash-free Net Working Capital to Revenue		 -25.59% -27.94% -31.54% -27.04% -29.21% -29.82% -22.19% -18.40% -19.62% -12.17% -17.68%
Debt-free Net Working Capital to Revenue		 34.48% 34.85% 36.44% 39.33% 42.72% 45.53% 49.73% 50.74% 51.91% 49.89% 50.42%
Net Working Capital to Revenue		 34.48% 34.85% 36.44% 39.33% 42.72% 45.53% 49.73% 50.74% 51.91% 49.89% 50.42%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.33 $2.07 $1.36 $0.59 $0.90 $0.41 $0.95 $0.16 $0.99 $0.56 $0.30
Adjusted Weighted Average Basic Shares Outstanding		 13.45M 13.53M 13.40M 13.26M 13.37M 13.33M 13.40M 13.41M 14.08M 13.78M 14.13M
Adjusted Diluted Earnings per Share		 $2.26 $2.00 $1.31 $0.58 $0.89 $0.40 $0.94 $0.16 $0.97 $0.56 $0.30
Adjusted Weighted Average Diluted Shares Outstanding		 13.91M 14.03M 13.88M 13.57M 13.55M 13.56M 13.54M 13.55M 14.18M 13.81M 14.25M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.63M 13.58M 13.50M 13.35M 13.24M 13.33M 13.32M 13.41M 13.40M 13.58M 13.88M
Normalized Net Operating Profit after Tax (NOPAT)		 27 23 14 4.54 8.30 5.50 9.74 2.55 6.69 7.18 9.38
Normalized NOPAT Margin		 11.41% 8.94% 6.17% 2.88% 5.04% 3.36% 6.89% 2.46% 5.64% 6.09% 7.94%
Pre Tax Income Margin		 16.62% 14.39% 10.70% 7.17% 10.32% 7.08% 12.28% 2.90% 10.12% 8.75% 11.78%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 21.38% 26.11% 36.85% 40.26% 45.38% 41.40% 37.34% 48.68% 42.17% 75.34% 62.97%
Augmented Payout Ratio		 23.16% 33.13% 50.42% 63.78% 83.90% 79.21% 94.91% 201.58% 238.79% 512.20% 372.26%

Frequently Asked Questions About Argan's Financials

When does Argan's fiscal year end?

According to the most recent income statement we have on file, Argan's financial year ends in January. Their financial year 2025 ended on January 31, 2025.

How has Argan's net income changed over the last 10 years?

Over the last 10 years, Argan's net income changed from $43.46 million in 2015 to $85.46 million in 2025, a change of 96.7%. Find out what analysts predict for Argan in the coming months.

What is Argan's operating income?
Argan's total operating income in 2025 was $88.20 million, based on the following breakdown:
  • Total Gross Profit: $140.99 million
  • Total Operating Expenses: $52.79 million
How has Argan revenue changed over the last 10 years?

Over the last 10 years, Argan's total revenue changed from $383.11 million in 2015 to $874.18 million in 2025, a change of 128.2%.

How much debt does Argan have?

Argan's total liabilities were at $484.37 million at the end of 2025, a 57.6% increase from 2024, and a 124.0% increase since 2015.

How much cash does Argan have?

In the past 10 years, Argan's cash and equivalents has ranged from $122.11 million in 2018 to $366.67 million in 2021, and is currently $145.26 million as of their latest financial filing in 2025.

How has Argan's book value per share changed over the last 10 years?

Over the last 10 years, Argan's book value per share changed from 12.76 in 2015 to 25.92 in 2025, a change of 103.1%.


Related Companies

This page (NYSE:AGX) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...
Golden Portfolio | Sponsored
Banks aren’t ready for this altcoin—are you?
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...
Crypto 101 Media | Sponsored
$19 for a FULL YEAR of stock picks?!
Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...
Behind the Markets | Sponsored
We’ve Entered the Most Bullish Phase of the Cycle
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Watch This Robotics Demo Before July 23rd
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...
Brownstone Research | Sponsored
Big Oil’s big pivot
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...
Stansberry Research | Sponsored
After Monday, price goes up 600% (hurry)
Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...
Timothy Sykes | Sponsored